Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Low Back Pain in Japan

Trial Profile

Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Low Back Pain in Japan

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Nov 2016

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Back pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 30 Sep 2016 Results of subgroup analysis based on the number of painful body sites (n=456) presented at the 16th World Congress on Pain.
    • 31 May 2016 New source identified and integrated (Japan Pharmaceutical Information Center - Clinical Trials Information JapicCTI132129).
    • 21 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top